our products
products
Systemic agent for funginal infection
Powder for concentrate for solution for infusion | 100 mg |
Tocolytic is indicated to delay imminent pre-term birth
Solution for injection | 6.75 mg/0.9 ml |
Concentrate for solution for infusion | 37.5 mg/5 ml |
Multiple myeloma
Powder for solution for injection | 3.5 mg |
indicated for the prevention of postpartum haemorrhage due to uterine atony after Caesarean section under epidural or spinal anaesthesia
Solution for injection | 100 mcg/ml |
Sedation of intubated patients in intensive care units and sedation of non-intubated patients before diagnostic or surgical procedures.
|
Concentrate for solution for infusion 100 µg/ml available in: |
200 µg/2 ml, 400 µg/4 ml, 1000 µg/10 ml |
Acutely decompensated severe chronic heart failure
| Concentrate for solution for infusion | 2.5 mg/ ml |
Systemic agent for funginal infection
| Powder for solution for infusion | 50 mg |
| Powder for solution for infusion | 100 mg |
For the reversal of neuromuscular blockade induced by rocuronium or vecuronium.
Solution for injections 100 mg/ml available | 200mg/ 2 ml; 500mg/ 5 ml |
Use for hypercalcemia of malignancy and bone metastases
Concentrate for solution for infusion | 4 mg/5 ml |
Find out more about our products, cooperation or career opportunities.